Concord Drugs Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
74.18 +1.85 (2.56%)Updated : 10 Apr 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net 0.600.46-0.193.46
Net Changein Cash -0.020.070.022.47
Cash Taxes Paid 0.200.220.380.67
Net Income/ Starting Line 0.690.631.252.25
Changesin Working Capital -0.41-3.25-2.84-4.64
Cashfrom Operating Activities 3.720.791.660.77
Cash Interest Paid 2.031.871.641.41
Cashfrom Financing Activities -1.430.280.621.68
Issuance( Retirement)of Stock Net 0.000.681.89-
Depreciation/ Depletion 1.431.561.631.76
Other Investing Cash Flow Items Total 0.010.01-1.410.01
Capital Expenditures -2.33-1.02-0.860.00
period Type ----
Non- Cash Items 2.011.861.631.40
Financing Cash Flow Items -2.03-0.86-1.07-1.78
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -2.32-1.01-2.270.01
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,414.00+23.00(1.65%)
801.40-42.95 (-5.09%)
979.80-40.25 (-3.95%)